| Literature DB >> 26459852 |
Giacomo Diaz1, Fausto Zamboni2, Ashley Tice3, Patrizia Farci4.
Abstract
BACKGROUND: Several studies have investigated miRNA and mRNA co-expression to identify regulatory networks at the transcriptional level. A typical finding of these studies is the presence of both negative and positive miRNA-mRNA correlations. Negative correlations are consistent with the expected, faster degradation of target mRNAs, whereas positive correlations denote the existence of feed-forward regulations mediated by transcription factors. Both mechanisms have been characterized at the molecular level, although comprehensive methods to represent miRNA-mRNA correlations are lacking. At present, genome-wide studies are able to assess the expression of more than 1000 mature miRNAs and more than 35,000 well-characterized human genes. Even if studies are generally restricted to a small subset of genes differentially expressed in specific diseases or experimental conditions, the number of potential correlations remains very high, and needs robust multivariate methods to be conveniently summarized by a small set of data.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26459852 PMCID: PMC4603994 DOI: 10.1186/s12864-015-1971-9
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Frequency distribution comprehensive of all pairwise miRNA-mRNA, miRNA-miRNA and mRNA-mRNA Kendall correlations. a ALF livers. b normal livers. c ALF livers after partial correlations calculated for the level of necrosis
Fig. 2Correlation between gene expression and level of necrosis in ALF livers. The plots show a selection of representative mRNAs positively (left) or negatively (right) correlated with the degree of necrosis in ALF livers with |R| > 0.9. The level of hepatic necrosis is on the X axis; the gene expression is on the Y axis. Presumably, mRNAs positively correlated with necrosis are produced by non-hepatocyte cells, whereas those negatively correlated with necrosis are produced by hepatocytes. Gene expressions were standardized to fit the same scale range. Multiple dots of the same gene (color) for each level of necrosis represent data of multiple samples
Fig. 3Gene expression corrected for necrosis. Data refer to the same mRNAs shown in Fig. 2. a control livers. b ALF livers. c ALF livers data expected for zero necrosis, obtained as the intercept of the regression between necrosis (X variable) and gene expression (Y variable). d correlation between control livers and original ALF livers data. e correlation between control livers and ALF livers data expected for zero necrosis
Fig. 4MDS mapping of mRNAs differentially expressed in ALF livers. MDS was applied to a 640 × 640 square matrix including the Kendall correlations among 109 miRNAs and 531 mRNAs differentially expressed in ALF livers. This figure shows only a subset of 87 mRNAs functionally related to CYP450, transcription factors, complement, HLA class II, monocytes/macrophages, T cells, T-NK cells and B cells. These nine functional classes are delimited by dispersion ellipses with a confidence of 1.6 standard deviations. A 360° rotation of 3D ellipses is shown in the Additional file 2: Movie 1. The nine ellipses are also shown in the next Figs. 5, 6, 7 and 8 for reference. The numbers in parentheses, on the right of gene symbols, are the fold changes of original data, not corrected for necrosis. A prominent segregation of leukocyte-related mRNAs from hepatocyte-related mRNAs is apparent
Fig. 5MDS density plot of mRNAs differentially expressed in ALF livers. The density plot was calculated for the MDS map of 531 mRNAs differentially expressed in ALF livers, including the 87 mRNAs of Fig. 3 (shown by large dots, symbols, original fold changes and dispersion ellipses) and the remaining 444 mRNAs (shown by small dots)
Fig. 6MDS density plot of miRNAs differentially expressed in ALF livers. The numbers in parentheses, on the right of miRNA symbols, are the fold changes of original data, not corrected for necrosis. The 17 green-outlined points are the miRNAs whose median correlation with mRNAs decreased more than 0.15 Kendall tau in ALF livers, whereas the red-outlined point is the only miRNA whose median correlation increased more than 0.15 Kendall tau (Additional file 4: Figure S1). The dispersion ellipses of functional mRNA clusters are shown for reference. The inset shows the complementarity of miRNA (cyan) and mRNA (yellow) MDS density plots
Fig. 7MDS mapping of the network of miRNAs and target mRNAs differentially expressed in ALF livers. For clarity, only the 87 mRNAs of the nine functional groups are shown. Target mRNAs were obtained from the microRNA.org database, selecting miRNA-mRNA pairs with conserved miRNAs and a good (<= −0.1) mirSVR score. The dispersion ellipses of functional mRNA clusters are shown for reference
Fig. 8MDS mapping of miRNAs with the same seed sequence, found among miRNAs differentially expressed in ALF livers. MiRNAs with the same seed sequence are encircled by small ellipses. Small blue and red ellipses indicate down-regulated and up-regulated miRNAs, respectively. The dispersion ellipses of functional mRNA clusters are also shown for reference. The complete sequence of these miRNAs is shown in the Additional file 5: Table S3
Fig. 9MDS mapping of mRNAs expressed in control livers. This figure is to be compared with Fig. 4. A 360° rotation of 3D ellipses is shown in the Additional file 3: Movie 2. The nine ellipses are also shown in next Figs. 10, 11, 12 and 13 for reference. The numbers in parentheses, on the right of gene symbols, are the fold changes
Fig. 10MDS density plot of mRNAs expressed in control livers. This figure is to be compared with Fig. 5
Fig. 11MDS density plot of miRNAs expressed in control livers. This figure is to be compared with Fig. 6
Fig. 12MDS mapping of the network of miRNAs and target mRNAs expressed in control livers. This figure is to be compared with Fig. 7
Fig. 13MDS mapping of miRNAs with the same seed sequence expressed in control livers. This figure is to be compared with Fig. 8
Functional classes of genes
| CYP family |
| CYP8B1 (-19), CYP4F3 (-28), CYP4F2 (-18), CYP4A11 (-7), CYP3A7 (-6), CYP3A5 (-5), CYP3A4 (-7), CYP39A1 (-7), CYP2J2 (-6), CYP2E1 (-14), CYP2D6 (-8), CYP2C9 (-8), CYP2C8 (-12), CYP2C19 (-7), CYP2C18 (-7), CYP2B6 (-10), CYP26A1 (-5), CYP1A2 (-14), CYP1A1 (-7) |
| Transcription factors |
| NR1I3 (-7), NR1I2 (-6), HNF4A (-5), FOXA3 (-7) |
| HLA class II |
| HLA-DRA (7), HLA-DQB1 (7), HLA-DQA1 (14), HLA-DPB1 (9), HLA-DPA1 (6), HLA-DOA (8), HLA-DMB (6), HLA-DMA (10), CD74 (6) |
| B cells |
| TNFRSF17 (14), SEL1L3 (6), POU2AF1 (32), MZB1 (18), IGLL3P (10), IGLJ3 (6), IGKV4-1 (7), IGKV1-5 (12), IGKC (13), IGHM (12), IGHD (5), FCRL5 (11) |
| Monocytes/macrophages |
| CD86 (5), CD163 (5), C1QC (6), C1QB (13), C1QA (10) |
| Cell proliferation |
| ZWINT (5), TOP2A (7), RRM2 (7), PRR11 (7), PRC1 (5), NDC80 (5), DLGAP5 (6), CDC20 (6), CCNB1 (5), BUB1B (5), ANLN (5), AKR1B10 (18) |
| T cells |
| VTCN1 (6), VSIG4 (10), TRAC (5), LAX1 (5), CD8A (7), CD3D (5), CD2 (8) |
| T-NK cells |
| SLAMF7 (9), RASGRP1 (7), PRDM1 (6), NKG7 (6), KLRK1 (6), GZMK (5), GZMH (7), GZMB (13), GZMA (12), GNLY (6) |
| Complementa |
| C9 (-118), C8G (-6), C8B (-36), C8A (-39), C6 (-10), C5 (-15), C4BPB (-20), C4BPA (-18), C3P1 (-19), C1S (-6) |
In parentheses are the fold changes of original data, not corrected for necrosis
aComplement components C1QC, C1QB and C1QA were attributed to monocytes/macrophages as these proteins are mostly produced by these cells